Avid Bioservices Inc logo

Avid Bioservices Inc - SERIES E

(Preferred)
NEW
NAS:CDMOP.PFD (USA)   10 1/2 % Conv Pfd Shs Series -E
$ 25.06 (0%) 09:42 AM EST
At Loss
P/B:
17.82
Volume:
-
Avg Vol (2M):
19.23K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
19.23K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Avid Bioservices Inc ( ) from 2014 to Jul 23 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Avid Bioservices stock (CDMOP.PFD) PE ratio as of Jul 23 2025 is 0. More Details

Avid Bioservices Inc (CDMOP.PFD) PE Ratio (TTM) Chart

To

Avid Bioservices Inc (CDMOP.PFD) PE Ratio (TTM) Historical Data

Total 0
  • 1
Avid Bioservices PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Avid Bioservices Inc (CDMOP.PFD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Avid Bioservices Inc logo
Avid Bioservices Inc
NAICS : 325412 SIC : 2834
ISIN : US05368M2052

Share Class Description:

CDMOP.PFD: 10 1/2 % Conv Pfd Shs Series -E
Description
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.